European Regulators Begin Accelerated Review of AstraZeneca's COVID-19 Vaccine Candidate, but FDA Widens Its Investigation Into Clinical Trial Illness
The odds that AZD1222 will win swift approval in the EU seem to be rising, but in the U.S., it might be a different story.